Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A

Insights

Prognostic models like MELD and Maddrey DF accurately predict 90-day mortality in alcoholic hepatitis patients in Canada. These tools are especially useful for identifying patients with a low risk of death.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Clinical Prognostics

Background:

  • Severe alcoholic hepatitis (AH) presents a significant risk of short-term mortality.
  • Accurate prognostication is crucial for managing AH patients.

Purpose of the Study:

  • To identify prognostic factors for 90-day mortality in Canadian AH patients.
  • To validate established prognostic models (MELD, Maddrey DF) in this population.

Main Methods:

  • Retrospective analysis of 122 hospitalized AH patients in Calgary (2008-2012).
  • Logistic regression identified independent risk factors for 90-day mortality.
  • Area Under the ROC Curve (AUC) evaluated model discrimination.

Main Results:

  • 17% of patients died within 90 days.
  • Independent predictors of mortality included age, female sex, INR, MELD score, and Maddrey DF.
  • MELD (AUC 0.64) and Maddrey DF (AUC 0.68) showed similar discrimination.
  • High negative predictive values (90% MELD, 96% Maddrey DF) identified low-risk patients.

Conclusions:

  • Established prognostic models are effective for predicting 90-day mortality in hospitalized AH patients.
  • These models are particularly valuable for identifying patients with a low likelihood of death.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
358
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
820